C-Path

Filter by Category

All Annual Meetings Blog Events Newsletters Podcasts Posters Publications Webinars Workshops

Filter by Program

Filter by Date

April 1, 2017

Challenges and Opportunities to Enhance Global Drug Development in Neonates

March 2, 2017

Safety, Dosing, and Pharmaceutical Quality for Studies That Evaluate Medicinal Products (Including Biological Products) in Neonates

Ward RM, Benjamin D, Barrett JS, Allegaert K, Portman R, Davis JM, Turner MA, and the International Neonatal Consortium. Safety, D

February 1, 2017

Validity of the Timed 25-Foot Walk as an Ambulatory Performance Outcome Measure for Multiple Sclerosis

February 1, 2017

The Nine-Hole Peg Test as a Manual Dexterity Performance Measure for Multiple Sclerosis

February 1, 2017

Validity of Low-Contrast Letter Acuity as a Visual Performance Outcome Measure for Multiple Sclerosis

February 1, 2017

Validity of the Symbol Digit Modalities Test as a Cognition Performance Outcome Measure for Multiple Sclerosis

February 1, 2017

A Drug Development Tool for Trial Enrichment in Patients With Autosomal Dominant Polycystic Kidney Disease

January 31, 2017

Clinically Meaningful Outcomes in Early Alzheimer Disease: A Consortia-Driven Approach to Identifying What Matters to Patients

January 12, 2017

A Standardised Method for Interpreting the Association Between Mutations and Phenotypic Drug Resistance in Mycobacterium Tuberculosis

January 12, 2017

Patient-Reported Outcome (PRO) Consortium Translation Process: Consensus Development of Updated Best Practices

Previous45 6...15 Next